A difficult to view Reuters article not reproduced in corporate media from last February reported that Pfizer dropped its Indian EUA vaccine application like a sizzling hyperdermic after the countryâs regulator demanded Pfizer conduct local safety and immunogenicity trials. Itâs over. These days, the vaccine is unavailable in both of the worldâs biggest countries, India and China.
After meeting with Pfizerâs application team, the Indian drugmaker said it could not approve that shot due to side effects and Pfizerâs failure to propose a plan to complete safety trials. But Indian company Dr. Reddyâs Laboratories Ltd is running trials for Russiaâs Sputnik V vaccine, which is expected to be approved this month or next.
You might be wondering why Pfizer wouldnât prove its safe and effective vaccine is safe and effective, but I get it. Since India is only the worldâs SECOND LARGEST MARKET, why throw more money into trials in India? If Indians want Comirnaty, they can wait 75 years for the US trial data like everybody else.
Google doesnât show ANY other corporate media article reporting the Reuters story in the year since it happened. So pass it on!
After meeting with Pfizerâs application team, the Indian drugmaker said it could not approve that shot due to side effects and Pfizerâs failure to propose a plan to complete safety trials. But Indian company Dr. Reddyâs Laboratories Ltd is running trials for Russiaâs Sputnik V vaccine, which is expected to be approved this month or next.
You might be wondering why Pfizer wouldnât prove its safe and effective vaccine is safe and effective, but I get it. Since India is only the worldâs SECOND LARGEST MARKET, why throw more money into trials in India? If Indians want Comirnaty, they can wait 75 years for the US trial data like everybody else.
Google doesnât show ANY other corporate media article reporting the Reuters story in the year since it happened. So pass it on!
âď¸ Coffee & Covid â Friday, May 13, 2022 â OFF RAMPS đŚ
Pfizer dumps the 2nd-largest market in the world, or vice-versa; a new CO2 mask study surprises; Psaki on formula; the Twitter deal sputters; Netflix tries to go un-woke; warmongering; and more...
www.coffeeandcovid.com